Maternal Serum Vascular Endothelial Growth Factor in Pregnant Women With Foetal Growth Restriction
NCT02245477 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2021-02-02
Summary
In this study we explore To explore the role of maternal serum vascular endothelial growth factor (VEGF) in pregnancies complicated by foetal growth restriction.
Conditions
- Foetal Growth Restriction
Interventions
- DEVICE
-
obstetric Ultrasound
Transabdominal ultrasound was performed to confirm foetal number, viability, gestational age, exclusion of congenital anomalies, and assessment of amniotic fluid index and localization of the placenta.
- OTHER
-
serum Vascular Endothelial Growth Factor
Maternal blood samples (10 cc) were taken from an antecubital vein. Plastic clean sterile tubes were used for collection of blood. Two cc of the blood sample were put in other clean sterile tubes containing ethylene diamine tetra-acetic acid (EDTA) to be used in measuring maternal hemoglobin concentrations and evaluating the complete blood count. The rest of maternal blood samples were centrifuged within 3 hours and sera collected equally in 2 suitable containers and stored at -80 degrees until assayed (first container for routine laboratory investigations and the second for VEGF assay).VEGF sample was allowed to clot for 30 minutes before centrifugation for 15 minutes. Serum is removed and assay immediately or sample was stored at -80 degrees
Sponsors & Collaborators
-
Beni-Suef University
lead OTHER
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2021-06-30
- Completion
- 2021-06-30
Countries
- Egypt
Study Locations
More Related Trials
-
Maternal and Neonatal Outcome in Severe Preeclampsia
NCT04126122 ·Status: UNKNOWN
-
FETAL PULMONARY VEIN AND UMBILICAL ARTERY PULSATILITY INDICES AS PREDICTORS OF FETAL GROWTH RESTRICTION IN DIABETIC AND HYPERTENSIVE PREGNANT WOMEN
NCT06988436 ·Status: COMPLETED
-
Placental Protein 13 Serum Endoglin and Uterine Doppler Indeces as Predictors of Pre-eclampsia
NCT02350036 ·Status: COMPLETED
-
Predicting Placental Pathologies by Ultrasound Imaging
NCT04506970 ·Status: COMPLETED
-
Vascular Endothelial Factor Gene Polymorphism in Preeclampsia
NCT03500588 ·Status: COMPLETED
-
Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection
NCT02506894 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Serum VEGF as a Tubal Pregnancy Marker
NCT02973230 ·Status: COMPLETED
-
Prediction of Placental Fetal Growth Restriction in High Risk Population (PoPFGR)
NCT06096805 ·Status: RECRUITING
-
LMWH for Treatment of Early Fetal Growth Restriction (HepaGrowth)
NCT04762992 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Doppler at the Diagnosis in Predicting Perinatal Outcomes in Early and Late-onset Fetal Growth Restriction
NCT05696223 ·Status: COMPLETED
-
Combined 3D Power Doppler Placental Volume and Vascular Flow Indices In the First Trimester of Pregnancy as Predictors Of Preeclampsia?.
NCT03399006 ·Status: UNKNOWN
-
Prediction of Outcome in Severe Preeclampsia
NCT03871764 ·Status: COMPLETED
-
Placental Imaging Techniques
NCT06861309 ·Status: RECRUITING ·Phase: NA
-
Fetal Growth Restriction: Management Using Two Guidelines - Fetal Growth Antenatal Management Evaluation
NCT05938829 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Fetal Cardiac Function and Vascular Hemodynamics in Intrauterine Growth Restriction
NCT03108040 ·Status: COMPLETED
-
Inter- and Multidisciplinary, Cross-sectoral Feto-neonatal Pathway
NCT04514276 ·Status: UNKNOWN ·Phase: NA
-
Relationship of DV Doppler Parameters to Perinatal Outcomes in IUGR vs Non-IUGR
NCT07190157 ·Status: NOT_YET_RECRUITING
-
The NICHD Fetal Growth Study: Twin Gestations
NCT01369940 ·Status: COMPLETED
-
qCTG and Doppler Ultrasound in the Detection of Hypoxia Among FGR Fetuses
NCT04447248 ·Status: COMPLETED
-
Serpin C and Soluble Fms-like Tyrosine Kinase-1 Levels in Normotensive Pregnant Women May Predict the Development of Preeclampsia
NCT06214702 ·Status: COMPLETED
-
EVERREST Developing a Therapy for Fetal Growth Restriction
NCT02097667 ·Status: COMPLETED
-
Evaluation of Serum Levels of C Reactive Protein (CRP) and Its Correlation With Fetal Ultrasound Parameters in the Prediction of Threatened Miscarriage in the First Trimester
NCT06011057 ·Status: COMPLETED
-
Maternal and Fetal Outcomes in Pregnant Women With COVID -19,a Cross Sectional Study
NCT05608616 ·Status: COMPLETED
-
Role of Inflammatory Markers and Doppler Parameters in Late-Onset Fetal Growth Restriction: A Machine Learning Approach
NCT06372938 ·Status: ACTIVE_NOT_RECRUITING
-
Validation of Ultrasound in Predicting a Low Lying Placenta Throughout Pregnancy
NCT02689739 ·Status: WITHDRAWN